Stay updated on Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The completed phase 3 KEYNOTE-006 study record is displayed, with details on pembrolizumab and ipilimumab treatment arms, participant criteria, measured outcomes, and related publications.
    Difference
    51%
    Check dated 2026-11-07T14:32:26.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.2 to v3.8.0, while the page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-31T15:36:52.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    An NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The requested study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-24T17:32:37.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T17:10:47.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1; the 403 error page otherwise remains the same.
    Difference
    0.2%
    Check dated 2026-10-10T18:07:35.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error with the site chrome (header/footer), replacing the previously visible study details and related content with an access-denied screen.
    Difference
    18%
    Check dated 2026-09-19T19:29:18.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Ipilimumab in Melanoma Clinical Trial page.